Note: Ingredients listed on restricted chemical lists
EC/CAS
9005-25-8
Name of the chemical
Starch
Concentration
N/A
EC/CAS
232-679-6
Name of the chemical
Starch
Concentration
N/A
General Information
Revision date
2011-03-09
Product name
CAPENON HCT
Product Synonyms
OLMETEC TRIPLO
Icons in SDS
Company Information
company name
Pfizer Inc
e-mail address of the competent person responsible for the Safety Data Sheet
pfizer-MSDS@pfizer.com
GHS Information
Signal word
DANGER
Section 2
SECTION 2: Hazards identification
Appearance: Tablets
Signal word
DANGER
Hazard statements
Causes severe eye damage. Suspected of damaging the unborn child. Toxic to aquatic life with long lasting effects.
Additional information
Short Term: Antihypertensive drug: has blood pressure-lowering properties Long Term: In humans, the use of drugs in this class can cause fetal and neonatal toxicity, including low blood pressure and kidney failure, when they are taken during the second and third trimesters of pregnancy. Known Clinical Effects: Effects reported during clinical use include dizziness, headache, lethargy, changes in blood pressure, nausea, and abdominal pain. Drugs of this class may cause electrolyte imbalance, dry mouth, muscle cramps, and muscle weakness EU Indication of danger: Toxic to Reproduction: Category 3 Dangerous for the Environment EU Hazard Symbols: EU Risk Phrases: R41 - Risk of serious damage to eyes. R63 - Possible risk of harm to the unborn child. R51/53 - Toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment. Australian Hazard Classification
Hazardous Ingredients
Non-Dangerous Goods (NOHSC): Note: This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.